In breast cancer, miR‐4532 stimulated cell proliferation, anti-apoptosis, disease pathogenesis, disease relapse/metastases and activation of STAT3 and TGFB pathways (Feng et al., 2018; Vora et al., 2024). Here, STAT3 is linked to breast carcinoma.